ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,815Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 262

$442K Total Retail Price of All Prescriptions

Rank: 36 out of 262

507 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 507 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 507 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 9,267 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LEVOTHYROXINE SODIUM 499 430 1 2
OMEPRAZOLE 464 389 2 5
FUROSEMIDE 408 389 3 4
SIMVASTATIN 380 324 4 1
LISINOPRIL 343 319 5 3
METOPROLOL TARTRATE 250 249 6 8
AMLODIPINE BESYLATE 227 213 7 6
METFORMIN HCL 221 180 8 9
POTASSIUM CHLORIDE 213 183 9 10
ALLOPURINOL 197 193 10 22
CITALOPRAM HBR 178 138 11 20
LOVASTATIN 168 168 12 80
HYDROCODONE-ACETAMINOPHEN 162 120 S3 13 15
ATENOLOL 156 135 14 16
WARFARIN SODIUM 150 143 15 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 122 16 24
LOSARTAN POTASSIUM 121 119 17 17
METOPROLOL SUCCINATE 111 101 18 11
PREDNISONE 110 98 19 29
AMITRIPTYLINE HCL 110 91 R 19 68
DONEPEZIL HCL 105 105 21 23
SERTRALINE HCL 104 100 22 14
CARVEDILOL 103 103 23 31
GLYBURIDE 96 94 R 24 89
HYDROCHLOROTHIAZIDE 95 89 25 7
ZOLPIDEM TARTRATE 93 93 26 26
ALENDRONATE SODIUM 92 76 27 21
TRAMADOL HCL 92 70 27 18
GABAPENTIN 92 74 27 19
DOXAZOSIN MESYLATE 92 81 27 59
POLYETHYLENE GLYCOL 3350 91 70 31 42
DIGOXIN 85 85 32 28
DICLOFENAC SODIUM 84 71 33 111
ATENOLOL-CHLORTHALIDONE 80 80 34 129
SPIRONOLACTONE 80 72 34 58
JANTOVEN 75 66 36 39
RANITIDINE HCL 70 57 37 62
LYRICA 70 43 37 86
ADVAIR DISKUS 70 67 37 34
ATORVASTATIN CALCIUM 66 61 40 13
LEVETIRACETAM 66 53 40 153
CLOPIDOGREL 64 64 42 38
TRIAMTERENE-HCTZ 62 62 43 32
ENALAPRIL MALEATE 62 55 43 27
METHADONE HCL 61 56 S2 45 196
LOSARTAN-HYDROCHLOROTHIAZIDE 60 60 46 43
BISOPROLOL-HYDROCHLOROTHIAZIDE 58 51 47 112
LANTUS SOLOSTAR 58 50 47 49
OXYCODONE HCL 57 57 S2 49 83
FENTANYL 56 45 S2 50 40
GLIPIZIDE 54 54 51 70
CEPHALEXIN 54 45 51 69
FLUOXETINE HCL 52 42 53 46
FLUTICASONE PROPIONATE 52 42 53 48
DIOVAN HCT 50 50 55 103
FINASTERIDE 50 50 55 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.